Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Invitrogen Presents Latest Trends in Stem Cell Technologies at ISSCR Meeting

Published: Monday, July 13, 2009
Last Updated: Monday, July 13, 2009
Bookmark and Share
Tutorials provide insight into pioneering approaches for culture and expansion of multiple human cell types.

Invitrogen, part of Life Technologies Corporation, will present major trends in stem cell technologies this week at the International Society for Stem Cell Research (ISSCR) 7th Annual Meeting in Barcelona, Spain.

The ISSCR meeting is the pre-eminent international stem cell conference, attracting more than 2,500 of the foremost stem cell professionals from public, private, academic and government organizations. Several presentations during the conference will highlight how Invitrogen products are enabling pioneering approaches to culture and expansion of multiple human stem cell types.

Life Technologies, through its Invitrogen portfolio of products, is playing a principal role in induced pluripotent stem cell (iPSC) research, working with collaborators from leading research centres to develop new tools and technologies to advance iPSC discoveries.

A number of products, for use across the iPSC workflow, will be highlighted during the conference, including ViraPower™ HiPerform™ reprogramming technologies, KnockOut™ SR XenoFree and StemPRO® serum-free media and growth factor cocktails, CELLstart™ xeno-free substrates and the Dynabeads® SSEA-4 extraction system.

Mohan Vemuri, Ph.D., Life Technologies’ Director of Stem Cells and Regenerative Medicine and Mahendra Rao, Ph.D., Life Technologies’ Vice President of Stem Cell Research, will present tutorials on the benefits of using Invitrogen’s XenoFree Media for growing human embryonic and induced pluripotent stem cells, mesenchymal stem cells and neural stem cells at the ISSCR meeting in Room 117.

For those not attending the conference, questions on these and other tutorials featuring Invitrogen products will be answered on the Invitrogen website. Questions can be submitted at www.invitrogen.com/stemcell/isscr09, where the panelists’ slides and answers will be available after the meeting.

Mohan Vemuri, Ph.D., Life Technologies’ Director of Stem Cells and Regenerative Medicine, “At Life Technologies, we believe that future use of stem cells for cell replacement therapies and tissue engineering is dependent on reliable, well-defined reagents prepared from animal-free origin. Our Invitrogen products have been an integral part of iPSC research since the initial discovery in 2006, and our latest products offer researchers more regulatory-friendly solutions to advance potentially ground-breaking stem cell therapies towards the clinic.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Invitrogen Introduces NCODE™ Human miRNA Microarray V3
The system includes content available from the Sanger database 10.0 as well as 373 novel sequences discovered through deep sequencing.
Monday, March 31, 2008
Scientific News
Diagnostic Thread - Weaving the Future?
Researchers have created diagnostic threads that could pave the way for next-gen implantable and wearable diagnostics.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Adipose Analysis on Microfluidic Chips
Scientists have developed a microfluidic chip the works with minute liquid quantities to grow and study cells.
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
DNA Production Facility Begins Operation
Scientists mark the opening of the UK's first fully automated DNA construction and modification facility.
A “Micro Winery” That Makes Wine Continuously
An American professor, working in collaboration with EPFL, is developing a miniature device for producing wine non-stop and testing different fermentation processes.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
Tough New Hydrogel Hybrid Doesn’t Dry Out
Water-based material could be used to make artificial skin, longer-lasting contact lenses.
Lasers Carve the Path to Tissue Engineering
A new technique, developed at EPFL, combines microfluidics and lasers to guide cells in 3D space, overcoming major limitations to tissue engineering.
A Future Tool for Medicine, Food Safety
A new type of electronic sensor that might be used to quickly detect and classify bacteria for medical diagnostics and food safety has passed a key hurdle by distinguishing between dead and living bacteria cells.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!